China YTC Announces Big Increase in Latest Quarter
publication date: Jan 27, 2009
China YCT International Group reported a 60% upsurge in Q3 (ended December 31) revenues to $8.6 million. Net income rose even more: it climbed 126% to $2.2 million. All figures are preliminary estimates. Through its subsidiary Shandong Spring Pharmaceutical Co., China YCT International manufactures and distributes ginkgo based products in China. More details...
Stock Symbol: (OTCBB: CYIG)
Sorry... this feature or article is only available to subscribers.